Kite Pharma, Inc. 4
4 · Kite Pharma, Inc. · Filed Jun 17, 2015
Insider Transaction Report
Form 4
Ruchefsky Steven B
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-06-09+10,000→ 10,000 totalExercise: $59.23Exp: 2025-06-08→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest in 12 equal monthly installments following the date of grant.